Strand Life Sciences, a subsidiary of Reliance Industries, has introduced CancerSpot, a blood-based test for early cancer ...
Strand Life Sciences, a subsidiary of Reliance Industries Limited, is a genomics-based research and diagnostics company that combines a long track record in bioinformatics with cutting-edge laboratory ...
Health and Me on MSN4h
Researchers Launch CancerSpot-A Blood test That Could Detect Cancer Even Before Symptoms AppearStrand Life Sciences has introduced CancerSpot, a blood-based test designed for the early detection of multiple cancers. This ...
Strand Life Sciences, a subsidiary of Reliance Industries, introduces CancerSpot, a new blood test for early cancer detection ...
Strand Life Sciences introduces CancerSpot, a blood-based test using methylation profiling for early detection of multiple ...
Genetic factors significantly influence breast cancer risk, with up to 10% of cases being hereditary. Key risk factors ...
Strand Life Sciences is a company based in Bengaluru, Karnataka, India, specialising in the healthtech sector. Founded in 2000, it now employs 533 individuals. The company was established by ...
Strand Life Sciences launches CancerSpot, a blood-based test for early cancer detection, using advanced methylation profiling ...
Strand Life Sciences introduces CancerSpot, a blood-based test using methylation profiling technology for early detection of multiple cancers. The test aims to address the growing cancer burden in ...
Stay up-to-date with the RIL Stock Liveblog, your comprehensive source for real-time updates and detailed analysis on a ...
Speaking at the opening of Strand’s new Genomics Diagnostics & Research Centre in Bengaluru, company CEO and Co-Founder Dr.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback